Literature DB >> 20484154

Mammalian target of rapamycin pathway promotes tumor-induced angiogenesis in adenoid cystic carcinoma: its suppression by isoliquiritigenin through dual activation of c-Jun NH2-terminal kinase and inhibition of extracellular signal-regulated kinase.

Zhi-Jun Sun1, Gang Chen, Wei Zhang, Xiang Hu, Cong-Fa Huang, Yu-Fan Wang, Jun Jia, Yi-Fang Zhao.   

Abstract

Tumor-induced angiogenesis is essential for invasive growth and hematogenous metastasis of adenoid cystic carcinoma (ACC), a highly aggressive neoplasm mostly occurring in salivary glands. Previous studies have indicated that strategies directed against angiogenesis will help develop new therapeutic agents for ACC. The Chinese folk medicine licorice has been used for years as a natural remedy for angiogenesis-related diseases. In this study, we examined the effects of isoliquiritigenin (ISL), a flavonoid isolated from licorice, on the growth and viability of ACC cells and observed a concentration-dependent (0-20 microM) inhibition of cell growth without cell death at 24 h. In a further mimic coculture study, ISL effectively suppressed the ability of ACC cells to induce in vitro proliferation, migration, and tube formation of human endothelial hybridoma (EAhy926) cells as well as ex vivo and in vivo angiogenesis, whereas it exerted no effect on EAhy926 cells when added directly or in the presence of vascular endothelial growth factor (VEGF). The data also showed that the specific suppression of tumor angiogenesis by ISL was caused by down-regulation of mammalian target of rapamycin (mTOR) pathway-dependent VEGF production by ACC cells, correlating with concurrent activation of c-Jun NH(2)-terminal kinase (JNK) and inhibition of extracellular signal-regulated kinase (ERK). Most importantly, ISL also significantly decreased microvessel density within xenograft tumors, associating with the reduction of VEGF production and suppression of the mTOR pathway coregulated by JNK and ERK, as revealed by immunohistochemical studies and clustering analysis. Taken together, our results highlight the fact that ISL is a novel inhibitor of tumor angiogenesis and possesses great therapeutic potential for ACC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20484154     DOI: 10.1124/jpet.110.167692

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  23 in total

Review 1.  The role of chalcones in suppression of NF-κB-mediated inflammation and cancer.

Authors:  Vivek R Yadav; Sahdeo Prasad; Bokyung Sung; Bharat B Aggarwal
Journal:  Int Immunopharmacol       Date:  2010-12-22       Impact factor: 4.932

2.  Inhibition of STAT3 reduces proliferation and invasion in salivary gland adenoid cystic carcinoma.

Authors:  Lin-Lin Bu; Wei-Wei Deng; Cong-Fa Huang; Bing Liu; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

3.  Inhibition of mTOR reduce Stat3 and PAI related angiogenesis in salivary gland adenoid cystic carcinoma.

Authors:  Guang-Tao Yu; Lin-Lin Bu; Yu-Yue Zhao; Bing Liu; Wen-Feng Zhang; Yi-Fang Zhao; Lu Zhang; Zhi-Jun Sun
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

4.  B7-H3 regulates migration and invasion in salivary gland adenoid cystic carcinoma via the JAK2/STAT3 signaling pathway.

Authors:  Teng-Fei Fan; Wei-Wei Deng; Lin-Lin Bu; Tian-Fu Wu; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

5.  Preparation and in vitro and in vivo evaluation of an isoliquiritigenin-loaded ophthalmic nanoemulsion for the treatment of corneal neovascularization.

Authors:  Rui Zhang; Jingjing Yang; Qing Luo; Jieran Shi; Haohang Xu; Junjie Zhang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 6.  Molecular targeted approaches to cancer therapy and prevention using chalcones.

Authors:  Danielle D Jandial; Christopher A Blair; Saiyang Zhang; Lauren S Krill; Yan-Bing Zhang; Xiaolin Zi
Journal:  Curr Cancer Drug Targets       Date:  2014       Impact factor: 3.428

7.  Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: correlation with enhanced metastatic potential.

Authors:  Hui Liu; Gang Chen; Wei Zhang; Jun-Yi Zhu; Zhao-Quan Lin; Zhong-Cheng Gong; Feng-Qin Wang; Jun Jia; Zhi-Jun Sun; Yi-Fang Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2012-10-12       Impact factor: 4.553

8.  MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma.

Authors:  Lu Zhang; Zhi-Jun Sun; Yansong Bian; Ashok B Kulkarni
Journal:  Cancer Lett       Date:  2013-01-20       Impact factor: 8.679

9.  Epidermal growth factor receptor inhibition reduces angiogenesis via hypoxia-inducible factor-1α and Notch1 in head neck squamous cell carcinoma.

Authors:  Wei-Ming Wang; Zhi-Li Zhao; Si-Rui Ma; Guang-Tao Yu; Bing Liu; Lu Zhang; Wen-Feng Zhang; Ashok B Kulkarni; Zhi-Jun Sun; Yi-Fang Zhao
Journal:  PLoS One       Date:  2015-02-27       Impact factor: 3.240

10.  Induction of autophagy-dependent cell death by the survivin suppressant YM155 in salivary adenoid cystic carcinoma.

Authors:  Yu-Fan Wang; Wei Zhang; Ke-Fei He; Bing Liu; Lu Zhang; Wen-Feng Zhang; Ashok B Kulkarni; Yi-Fang Zhao; Zhi-Jun Sun
Journal:  Apoptosis       Date:  2014-04       Impact factor: 5.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.